Matt Norlander's annual year in review highlights the SEC's epic year, Sister Jean, Kentucky, Kansas, portal mania, gambling ...
That being said, it looks like 2026 is more than ready to rise to the challenge. While we clearly don't know all the films ...
Reporter Katie Klingsporn also spent much of the year following rural health care challenges, library battles and a notorious shortcut.
For years, goal songs have signaled joy in NHL arenas. Our staff rated each one, based on personal opinions and how the tune fits the team.
The Rolling Stones were already veterans of the music business—for better or worse—by the time 1989 rolled around. With that experience came a fair bit of tension, whether due to drugs or legal issues ...
A woman from Connecticut just became the biggest winner in the history of "Wheel of Fortune." Stamford resident Christina Derevjanik won $1,035,155 on the Ryan Seacrest-hosted game show that aired on ...
Most years, Time Magazine names a person who “for better or for worse … has done the most to influence the events of the year.” The first-ever honoree was Charles Lindbergh in 1927, honored for being ...
The Detroit Lions thought they were going to get a massive boost to their offense when four-time Pro Bowl center Frank Ragnow came out of retirement to rejoin the team. However, the Lions announced ...
Rafa Benitez's 19-month wait for a managerial role is about to end, with the Spaniard set to be appointed in his 17th job.
NEWARK, NJ - The Devils snapped a three-game losing streak with the help of some home cooking. New Jersey topped Detroit, 4-3, at Prudential Center on Monday night. Timo Meier, Nico Hischier, Cody ...
Damian Garde is a reporter at large, live and feature journalism, covering the global drug industry and contributing to STAT’s industry-leading events. Jason Mast is a general assignment reporter at ...
Semaglutide fails to slow progression of Alzheimer’s in highly anticipated trials, Novo Nordisk says
An oral version of semaglutide, the active ingredient in blockbuster drugs Ozempic and Wegovy, failed to slow the progression of Alzheimer’s disease in closely watched trials, drugmaker Novo Nordisk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results